US Pharma MarketingThe post Boston Scientific expects headcount reductions amid restructuring initiative appeared first on Medical Device Network.
Boston Scientific expects headcount reductions amid restructuring initiative
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029. The post Boston Scientific expects headcount reductions amid restructuring initiative appeared first on Medical Device Network .
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029.
Source: Medical Device Network